Julia M. Selfridge

发表

Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.

Jerry J. Lou, T. Cloughesy, L. Liau, 2013, Neuro-oncology.

Opening the Debate: How to Fulfill the Need for Physicians’ Training in Circadian-Related Topics in a Full Medical School Curriculum

C. Finkielstein, D. Capelluto, K. Moyer, 2015, Journal of circadian rhythms.

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.

Jerry J. Lou, Ryan W. Wilson, R. Elashoff, 2013, Neuro-oncology.

Laminin alpha 2 enables glioblastoma stem cell growth

R. McLendon, Qiulian Wu, M. Bredel, 2012, Annals of neurology.

Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.

Ryan W. Wilson, S. Nelson, T. Cloughesy, 2012, Journal of the National Cancer Institute.

Chronotherapy: Intuitive, Sound, Founded…But Not Broadly Applied

C. Finkielstein, D. Capelluto, Julia M Selfridge, 2016, Drugs.

Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.

T. Cloughesy, L. Liau, W. Pope, 2014, Neuro-oncology.

Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

T. Cloughesy, L. Liau, P. Mischel, 2013, American Journal of Neuroradiology.

Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy.

B. Czerniecki, Q. Mo, Junmin Whiting, 2022, Clinical breast cancer.